Our Research
Our July 9th, 2019 Value Report on (NASDAQ: IEA) Now Providing Over 35% in Gains
Good morning everyone, Update (NASDAQ: IEA) We brought a report on IEA on July 9th, 2019 at $2.86/share. Following their 2nd quarter 2019 result...
Biotech Company with Impressive Market Potential
INmune Bio has a remarkable technology platform Three products ready to enter clinical trials Good day everyone, Today we are continuing our coverage ...
Biotech Companies with Recent and Near-Term Potential Catalysts
Northwest Biotherapeutics, Inc. (OTCQB: NWBO), a biotechnology company focused on developing DCVax®, personalized immune therapies for solid tumor can...